MARKET OF PHARMACEUTICAL PRODUCTS OF UKRAINE: PROBLEMS AND PROSPECTS OF DEVELOPMENT

Abstract

The dynamic development of the latest technologies has created many opportunities for pharmaceutical companies to create new products and medicines. Along with the opportunities every day on a global scale, global problems arise that require the pharmaceutical market to solve them: the aging of nations, bad ecology, pandemics, war, depression of globalized cities and, as a result, the strengthening of chronic diseases in the population. Ukraine was no exception in these processes. The article examines the current state and prospects for the development of the pharmaceutical market of Ukraine. Statistical reports, reports of international organizations and the largest pharmaceutical companies were studied, and conclusions were drawn about the future state of the domestic pharmaceutical market. It has been established that the Ukrainian pharmaceutical market is represented in the vast majority by pharmacies and legal enterprises that are trying to spread their network in the largest cities of Ukraine. It was determined that the pre-war period was characterized by a dynamic increase in the number of pharmacies and pharmacy points throughout the country, the entry of the largest pharmaceutical markets to the international level. It is outlined that according to the number of residents who have access to one pharmacy, domestic pharmaceutical enterprises have the lowest rate among the CIS countries and Europe, therefore there are more than enough development prospects for pharmacies, pharmacy points and pharmaceutical products. The impact of the war on the domestic pharmaceutical market was analyzed, and it was noted that in the first two months, as a result of panic and excitement, the population bought all the most common medicines without taking into account their need and purpose. As a result of a significant decrease in the level of consumer incomes and the occupation of a large part of the country, pharmaceutical companies experienced a significant reduction in activity, a decrease in income and profit. Most international and domestic analysts predict a further reduction in the volume of retail sales of pharmaceutical products, and therefore most pharmaceutical companies have begun to differentiate their business and look for new alternative sources of increasing revenues and sales of pharmaceutical products.